Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Cipla
Cantor Fitzgerald
McKinsey
Johnson and Johnson
McKesson
Federal Trade Commission
Farmers Insurance
Merck
Harvard Business School

Generated: February 25, 2018

DrugPatentWatch Database Preview

FERRIPROX Drug Profile

« Back to Dashboard

Which patents cover Ferriprox, and what generic alternatives are available?

Ferriprox is a drug marketed by Apopharma Inc and is included in two NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has forty-two patent family members in twenty-four countries.

The generic ingredient in FERRIPROX is deferiprone. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the deferiprone profile page.
Summary for FERRIPROX
Drug patent expirations by year for FERRIPROX
Pharmacology for FERRIPROX
Drug ClassIron Chelator
Mechanism of ActionIron Chelating Activity

US Patents and Regulatory Information for FERRIPROX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apopharma Inc FERRIPROX deferiprone SOLUTION;ORAL 208030-001 Sep 9, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Apopharma Inc FERRIPROX deferiprone TABLET;ORAL 021825-001 Oct 14, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apopharma Inc FERRIPROX deferiprone SOLUTION;ORAL 208030-001 Sep 9, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apopharma Inc FERRIPROX deferiprone SOLUTION;ORAL 208030-001 Sep 9, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apopharma Inc FERRIPROX deferiprone TABLET;ORAL 021825-001 Oct 14, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for FERRIPROX
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Tablets 500 mg ➤ Subscribe 1/29/2016

International Patents for FERRIPROX

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Moodys
Federal Trade Commission
Express Scripts
US Department of Justice
Fuji
Citi
AstraZeneca
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot